Clinical trials: Migrainous Vertigo
Vestibular Migraine
Galcanezumab for Vestibular Migraine
Vestibular migraine (VM) has been recognized a distinct subtype of migraine that causes dizziness as the predominant symptom. Criteria for diagnosis have been adopted by the Barany Society.
- Trial name
- NCT04417361
- Testing
- Galcanezumab Prefilled Syringe
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, San Francisco
Migraine Associated Vertigo, Tinnitus
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Many people with migraine also experience tinnitus - a persistent ringing, buzzing, or hissing in the ears - and research suggests these conditions share underlying biological mechanisms, including a protein called calcitonin…
- Conditions
- Migraine Associated Vertigo, Tinnitus, Migraine, Vestibular Migraine
- Trial name
- COMPACT-PM (NCT07655440)
- Testing
- Galcanezumab, Erenumab 70 mg, Eptinezumab
- Volunteers
- 120 people
- Sponsor
- Stanford University
Vestibular Migraine, Adults 18 Years and Older (no Other Exclusion Criteria)
A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment
Vestibular migraine (VM) is one of the most common vestibular disorders, affecting 1.0% to 2.7% of the general population1, 7% of patients with definite migranous vertigo in dizziness clinics2, as well as 10.3% of VM patients in…
- Trial name
- NCT06748664
- Testing
- Rimegepant
- Volunteers
- 240 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Headache Disorders, Primary, Headache Disorders, Secondary
China Headache and Vertigo Registry Study
In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular…
- Conditions
- Headache Disorders, Primary, Headache Disorders, Secondary, Migraine, Tension-Type Headache
- Trial name
- CHRS (NCT04939922)
- Where
- China
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Vestibular Migraine
Local Sensory Nerve Block in the Treatment of Vestibular Migraine
There is no standard approach to the treatment of vestibular migraine. Agents used in the treatment of migraine are frequently used.
- Trial name
- NCT05472675
- Testing
- Botulinum toxin and bupivacain
- Where
- Turkey (Türkiye)
- Volunteers
- 29 people
- Sponsor
- Pamukkale University
Migraine Disorders, Migraine Variant
Vestibular System in Migrainous Vertigo Patients
Do migrainous vertigo patients have more pathology in their vestibular system than migraine patients without vertigo? The aim of this study is to compare the vestibular system of migraine patients with and without vertigo in the…
- Conditions
- Migraine Disorders, Migraine Variant, Episodic Recurrent Vertigo
- Trial name
- NCT00901953
- Where
- Norway
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- University of Bergen
Vestibular Migraine
The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines
The goal of this clinical trial is to learn if the Otolith Labs device can improve vestibular function of subjects with vestibular migraine.
- Trial name
- VIBRANT-VM (NCT06540235)
- Testing
- Otolith Device Active, Otolith Device Inactive
- Where
- 2 sites in United States
- Volunteers
- 51 people
- Sponsor
- Otolith Labs
Definite Vestibular Migraine, Migraine
Findings Of The Video Head Impulse Test In Patients With Vestibular Migraine
VHIT Sometimes demonstrate preserved semicircular canal function with corrective ,normal VOR gain or mild abnormalities
- Trial name
- NCT07796633
- Testing
- No Intervention: Observational Cohort
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Sohag University
Vestibular Migraine
The Role Of Vestibular Rehabilitation Therapy In Management Of Vestibular Migraine Patients
1. To assess the criteria of positional vertigo in vestibular migraine patients 2. To assess the effect of vestibular rehabilitation therapy in management of positional vertigo in vestibular migraine patients
- Trial name
- NCT05508139
- Volunteers
- 30 people
- Sponsor
- Assiut University
Vestibular Migraine
Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
Vestibular migraine (VM) is one of the most common causes of vertigo attacks, affecting 1 - 5% of people. People with vestibular migraine have lower quality of life compared to others and some may experience completely…
- Trial name
- RCTVM (NCT06417684)
- Testing
- Amitriptyline, Lifestyle Modification
- Where
- United States
- Sponsor
- Vanderbilt University Medical Center
Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Migraine
Metabolic Disorders and Vertigo
The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine).
- Conditions
- Benign Paroxysmal Positional Vertigo (BPPV), Vestibular Migraine, Central Positional Vertigo, Vestibular Neuritis
- Trial name
- NCT04935970
- Testing
- diagnostic blood test, neuropsychological test
- Where
- Russia
- Volunteers
- 100 people
- Sponsor
- I.M. Sechenov First Moscow State Medical University
Cognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine
Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine
The management of vestibular migraine is multifaceted and includes both pharmacological and non-pharmacological approaches. Aim of work Evaluate the efficacy of adding Cognitive Behavioral Therapy (CBT) to standardized Medical…
- Trial name
- NCT07849283
- Testing
- •Group A: Patients will receive Medical treatment only: Beta-blockers (Propranolol) , Calcium channel blockers, Group B: Cognitive Behavioral Therapy (CBT) +Medical treatment
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Sohag University
Vestibular Migraine
Health Belief Model Scale Development for Disability and Abilities in Vestibular Migraine Patients
Vestibular migraine (VM) is a neurological condition characterized by recurrent episodes of dizziness, imbalance, and migraine-related symptoms. Individuals' responses to health problems are influenced by their health beliefs.
- Trial name
- NCT07469748
- Testing
- Vestibular Migraine Education / Awareness Session
- Where
- Turkey (Türkiye)
- Volunteers
- 213 people
- Sponsor
- Istanbul Aydın University
Vestibular Migraine
Assesment of Hearing in Patients With Vestibular Migra
Evaluation of hearing in patients with vestibular migraine
- Trial name
- NCT05396482
- Testing
- Pure tone audiometer
- Where
- Egypt
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Rahma Alaa Kamel
Vestibular Migraine
A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study
Vestibular migraine is a common condition that causes repeated episodes of dizziness or vertigo, often with migraine headaches, sensitivity to light and sound, and nausea.
- Trial name
- VERIFY (NCT07751497)
- Testing
- Rimegepant, Flunarizine
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Vertigo, Meniere's Disease
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes
Aim of this work was to assess the role of polymorphisms belonging to genes involved in the regulation of ionic homeostasis in Caucasian patients with Ménière Disease (MD) and compare results with a cohort of patients affected by…
- Conditions
- Vertigo, Meniere's Disease, Vestibular Migraine
- Trial name
- Menière09 (NCT07518069)
- Testing
- a blood withdrawal will be obtained, blood withdrawal
- Where
- Italy
- Volunteers
- 250 people, healthy volunteers welcome
- Sponsor
- IRCCS San Raffaele
Vestibular Migraine, Migraine Associated Vertigo
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
The goal of this virtual clinical trial is to compare the effectiveness of two study devices in providing temporary relief to adults aged 18-75 who suffer from symptoms of chronic Vestibular Migraines (VM), also known as Migraine…
- Trial name
- NCT06267924
- Testing
- Otoband Experimental
- Where
- United States
- Volunteers
- 322 people
- Sponsor
- Otolith Labs
Vestibular Migraine
Acupuncture for Prophylaxis of Vestibular Migraine
With its high incidence rate and low diagnosis rate, vestibular migraine (VM) can seriously affect patients' quality of life. Current treatment of VM mainly contain rescue treatment and prophylaxis, both of which are often…
- Trial name
- NCT04664088
- Testing
- Acupuncture, Venlafaxine
- Where
- China
- Volunteers
- 72 people
- Sponsor
- Affiliated Hospital of Jiaxing University
Headache Disorders, Primary, Headache Disorders, Secondary
International Headache Registry Study
In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as…
- Conditions
- Headache Disorders, Primary, Headache Disorders, Secondary, Migraine, Tension-Type Headache
- Trial name
- IHRS (NCT05418218)
- Where
- China
- Volunteers
- 200,000 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Vestibular Migraine, Dizziness
Chinese Real-world Study of Treatment of Vestibular Migraine
Vestibular migraine is a phenotype of migraine, characterized by more prominent vertigo symptoms compared to headache. Treatments for VM are mainly divided into two categories: acute treatment and preventive treatment.
- Conditions
- Vestibular Migraine, Dizziness, Vertigo
- Trial name
- NCT07203248
- Testing
- CGRP R Inhibitor; CGRP Inhibitor, none-CGRP
- Volunteers
- 2,000 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine